Good Lifestyle

Johnson's Covid Vaccine & Johnson faced the controversy this month afterReports of rare blood clots Emergencined among a handle recipient of the single dose vaccine. This resulted in both disease control and prevention centers (CDC) and the US Food and Medicine Administration (FDA) jointly recommending that suppliers pause the use of the use of theJohnson & Johnson Vaccine April 13 until new research is completed. Now, a week in the break, another member of the Johnson & Johnson team gave an update on what the pharmaceutical company thinks of the risks of its vaccine. Read it to find out what the Chief Scientific Officer of the Company said and for more Johnson & Johnson vaccine blood clots, checkDr. Faisci has just said that this medicine could do worst blood clots.

During a gains call on April 20, Johnson & Johnson's Scientific DirectorPaul Stoffels, MD, said the company believes that the benefits of its Covid vaccine far awayProvide the potential risks. "We continue to believe in the positive profile of the benefits / risks of our vaccine," Stoffels said, according to CNN. "Given the Rage pandemic that continues to devastate the communities of the world, [we] continue to collaborate with medical experts and global health authorities, including the CDC, the FDA, the EMA, WHO and L South African Health Products Regulatory Authority, Sahpra -Ausfi We are working on continuous vaccination to end the global pandemic. "

Stoffels added that the company's absolute priority is "the safety and well-being of people who use [their] product".

"We strongly support the awareness of the signs and symptoms of this extremely rare event in order to ensure the correct diagnosis, the appropriate treatment and the accelerated report of health professionals," he added. And for more a much more common side effect,Moderna provoked this reaction in 82% of people, the new study says.

In a Joint Declaration of the CDC and the FDA on April 13, the agencies declared that they return to the data relating to the six cases of U.S. Reported of a rare and severe type ofblood clot in individuals"After receiving the Johnson & Johnson vaccine." In these cases, a type of blood clot called venous sinus cerebral thrombosis (CVST) was observed in combination with low levels of blood platelets (thrombocytopenia), "the statement read.

All six of the first reportedBlood clots have taken place in women From 18 to 48 years and all the symptoms took place six to 13 days after receiving vaccination.A woman is dead and a second was hospitalized and is in critical condition, byThe New York Times.The temperature Also reported on two other cases: a man who received the Johnson & Johnson vaccine during a clinical trial and a seventh woman who received the vaccine after receiving an emergency authorization by the FDA in February.

According to the CDC, more than 17.6 million people in the United States haveReceived Johnson & Johnson Vaccine, as of April 20th. Overall, this means that 8 to 17.6 million Johnson & Johnson recipients experienced the adverse effect, which is an extremely low rate of 0.000045%.

According toThe CDC, If you encounter serious headaches, abdominal pain, leg pain or shortness of breath in the three weeksAfter getting the Johnson & Johnson vaccineYou must contact your health care provider. And for more signs of blood clots, checkIf you have 1 of these 8 side effects, the CDC says "Consult medical care urgently".

The European Medicines Agency (EMA) announced on April 20 that it had found aPossible link between rare blood clotsand Johnson's Covid Vaccine & Johnson. However, as Stoffels, the Agency has always stated that the benefits of the vaccine outweigh potential risks. Although Johnson & Johnson has made the decision to "delay the deployment" of his vaccine in Europe, the EMA has ruled that it can now be administered throughout the continent, but it must include a warning.

"The EMA Security Committee (PRAC) concluded that a warning on unusual blood clots with low blood platelets needed to be added to JACCINE COVID-19 JANSSEN 's products information," said the Agency in a statement. "The PRAC also concluded that these events should be listed as very rare side effects of the vaccine." And for more new Covid vaccine news up-to-date,Sign up for our daily newsletter.

The CDC Advisory Committee on Vaccination Practices (ACIP) met last week on April 14 to discuss the potential risks of Johnson & Johnson vaccine, but did not make any decision tolift the pause. Instead, the organization recognizes on Friday, April 23 to discuss additional risk after collection and examination more data.

Anthony Fauci, MD, Chief Medical Advisor White House, said he does not believe an extension on theJohnson & Johnson vaccination break will extend last Friday. "We should have an answer as to where we are going with it. ... There will probably be a decision," said Fauci on ABCThis weekApril 18th.

Although he does not believe that the CDC will advise a cancellation of the Johnson & Johnson vaccine, it imagines it that it will come with a warning, such as the recommended EMA, or it will be limited for use among some people, considering in most cases. in women under 50 years old.

"I think there will probably be a kind ofWarning or restriction or risk assessment. ... I do not know what it will be, if they will be age or sex, "faluched onMeet the pressApril 18th. "I do not think it's just going back and say," OK, everything is fine, go right away. "I think it will probably say," Okay, we will use it. But be careful in these circumstances. " And for more factors that you can put yourself at the risk of a blood clot in general,If you have this type of blood, you are more likely to get blood clots.